drugset / Trial / NCT06888362
Trial to Investigate GZ21T in Healthy Volunteers
Phase 1
Completed
41 enrolled
Genzada Pharmaceuticals USA, Inc.
CTC Clinical Trial Consultants AB · collab
RandomizedSequentialTriple-blindTreatment
Summary
This is a double-blind, randomised, placebo-controlled trial designed to evaluate safety, tolerability, and pharmacokinetics (PK) after topical administration of single ascending doses of GZ21T in healthy volunteers.
Timeline
- Start
- 2024-08-19
- Primary completion
- 2025-03-31
- Completion
- 2025-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GZ21T | Unknown | 13 unknown | Topical |
| Subject | GZ21T | Unknown | 25.5 unknown | Topical |